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POLIOMYELITIS: HISTORY, PATHOGENESIS, GLOBAL IMPACT,  
PREVALENCE IN PAKISTAN AND METHODS TO ERADICATE 
TARIK BABAR 
ABSTRACT 
By the 1950s, poliomyelitis (polio) was a major public health and medical issue as it 
became one of the most communicable diseases for children in the United States and 
globally. Following the widespread use of vaccinations in the 1950s, and an increased 
global effort in the late 1980s, cases of polio reduced exponentially in countries that were 
able to enroll widespread vaccination to their citizens. The elementary pathogenic process 
includes central nervous system (CNS) involvement which may lead to paralysis in 
extreme rare circumstances. Through mass-vaccination campaigns and global efforts led 
by the World Health Organization (WHO), United Nations Children’s Fund (UNICEF), 
and the Bill & Melinda Gates Foundation, the number of new cases has remained 
minimal in most of the developed world except in three countries: Pakistan, Afghanistan, 
and Nigeria. There are multiple reasons why this disease continues to spread in these 
countries including vaccine-derived disease associated with mutations, geographical 
logistics, and the presence of anti-vaccine terrorist groups. While this review aims to 
explore the history, pathogenesis, and epidemiology of polio, a focus will also be placed 
on why the disease is still prevalent in Pakistan and novel methods that can be taken to 
ensure that polio is eradicated in the country. The goal should be for poliomyelitis to join 
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the ranks of smallpox and rinderpest, the only two diseases that have ever been 
completely eradicated through the use of vaccinations and global cooperation.   
vi 
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In the first part of this review, the background, vaccine, pathogenesis, and epidemiology 
of poliomyelitis will be discussed in relation to the timeline of world events. Also, the 
lasting effects that polio outbreaks had on healthcare will explored. The efficacy of 
vaccines and the progression and decline of the disease will be discussed using data from 
the literature. Although poliomyelitis has been eradicated in nearly all countries, the 
review will focus on why and how polio is still endemic in certain parts of the world such 
as Pakistan and Afghanistan, as well as novel steps that should be taken to achieve global 
eradication.   
 
 
Initial Outbreaks  
 
Poliomyelitis (polio) is a disease that is caused by the highly infectious poliovirus that is 
part of the Picornaviridae family of viruses. The virus can be spread from ingestion of 
infected fecal matter in food or water and more rarely, via infected saliva.  
Fortunately, relative to other diseases, polio has been well-documented due to it being 
characterized more recently in history, first documented in the 1800s. Despite this, there 
is still debate among researchers whether or not polio has been around for millennia prior 
to causing major outbreaks in the late 1800s. An Egyptian stele that dates back to the 18th 
century showcases a man propped up by a crutch due to a limp leg, which many 
researchers believe to be a very similar clinical presentation to modern day asymmetric 
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paralysis caused by polio [53]. Although polio may have been around longer than experts 
know, cases were first reported in the late 19th century. In the late 1890s and the early 
1900s, outbreaks of paralysis in infants were seen in countries such as Austria, Germany, 





















Figure 1. Infantile Paralysis Outbreaks in Various Countries in the Early 1900s. 
Outbreaks of infantile paralysis in European Countries and the United States (U.S.) were 
seen nearly simultaneously. Figure from [1]. 
 
There remains debate as to why these sudden outbreaks occurred almost simultaneously. 
Many experts believe that the outbreaks were due to the increase patient age at which 
poliovirus infections were occurring [1]. Prior to these outbreaks, it is hypothesized that 
the enteric poliovirus infections were occurring in infants aged 6-12 months, a 
developmental time frame in which maternal antibodies are circulating and protecting 
infants from paralytic and CNS-involved polio infection. With the advancement of 
overall sanitation and hygiene, it is possible that the transmission of polio was delayed so 
that infants were becoming infected after 12 months of age, a developmental time frame 
when maternal antibodies are reduced, leading to an increased number of reported 
outbreaks of infantile paralysis around the world. This hypothesis can explain why 
outbreaks initially occurred in more developed countries where sanitation was most 
advanced, while less developed countries exhibited a lag in outbreaks, until they also 
advanced overall sanitation and hygiene. Coinciding with the hypothesis, the average age 
of patients that were diagnosed with polio was increasing over the years, as seen in 




















Figure 2. Poliomyelitis Patient Age Ranges in Massachusetts. Each year range studied 
shows an increase in the percentage of older patients being diagnosed with poliomyelitis. 
This data agrees with the hypothesis that increased hygiene over the years lead to 
outbreaks in older ages. Figure from [2].  
 
An important study performed by Gunnar Olin looked at the epidemiological pattern of 
poliomyelitis in Sweden from the years 1925-1944, focusing on the severity and the 
clinical pathogenesis of polio in different age groups. Olin found that the case-fatality 
rate, which represents the proportion of patients that die due to acute polio within 1-2 
months after onset of disease, significantly increased with age [3]. Therefore, the 
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likelihood of severe illness involving paralysis and/or the respiratory system was 
significantly higher in older patients, as shown by Table 1 [3]. 









Gunnar Olin’s study in Sweden found that the case-fatality rate and likelihood  
of severe paralysis involving the respiratory system increased significantly with  
age. Data from [3]. 
 
 
By the mid-1950s, paralytic polio had affected more than 50,000 people causing a major 
public health issue [4]. Travel between cities in the U.S. became restricted, and 
quarantines were imposed on citizens in an effort to diminish the spread of the disease. 
The disease exhibited seasonality peaking in the summer [7]. Polio quickly became one 
of the most communicable and feared diseases globally. In the mid-1950s and early 
1960s, two vaccines were developed. Following its widespread use in the 1950s, the 
number of cases reduced dramatically, especially paralytic cases [4]. In the late 1980s, a 
global effort led by the WHO to eradicate polio led to an exponential decrease in the 
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number of cases. After further WHO intervention in the early 2010s, polio was nearly 





The following thesis will focus on the: 
 
1. History, pathogenesis, and global epidemiology of poliomyelitis  
2. Background and review of the literature to explore the efficacy of poliomyelitis 
vaccination using time frames as reference to showcase the effect of the polio 
vaccine on healthcare 
3. Reasons for why poliomyelitis is still endemic in Pakistan and investigation into 
the current options being employed to eradicate the disease 
4. Exploration of possible novel options to fight towards eradication in Pakistan 
5. Conclusion on the efficacy of current eradication techniques and what can be 




HISTORY, MICROBIOLOGY, PATHOGENESIS, AND EPIDEMIOLOGY 
 
Microbiology and Pathogenesis 
 
Poliovirus is a human enterovirus that causes poliomyelitis. The virus binds to a specific 
surface receptor called poliovirus receptor (PVR), that exists in humans but also in 
monkeys [5]. Infection by poliovirus is highly contagious via fecal-oral transmission and 
more rarely, oral-oral transmission. Upon ingestion, the virus binds to the lymphoid 
tissue in the tonsils and subsequently the gut. It then replicates and is able to move either 
through the blood brain barrier or through the peripheral nerves. Once in the blood 
stream, the virus causes viremia and can cause a viral prodromal syndrome consisting of 
sore throat, fever, nausea, and vomiting. A generalized depiction of this process is shown 
in Figure 3. If the virus invades the CNS, it is able to replicate in motor neurons. Rarely, 
the virus can undergo lytic replication and can cause destruction of neurons resulting in 
paralytic polio. Paralytic polio usually occurs in less than 1% of patients infected with 
poliovirus [5]. Using cryoelectron microscopy, researchers have determined the rather 
simple structure of the virus to be a single-stranded, non-enveloped RNA virus. The 
three-dimensional structure has shown to have “canyons” which serve as PVR attachment 
sites [6]. Upon binding to its receptor at physiological temperature, poliovirus undergoes 




















Figure 3. Poliovirus Transmission in the Human Body. Pathogenesis of poliovirus in 
the human body. Figure from [5]. 
 
Poliovirus has been classified into three serotypes: poliovirus type 1 (PV1), type 2 (PV2), 
and type 3 (PV3), differing in the composition of their capsid protein. Although nearly 
95% of patients are asymptomatic or exhibit minor symptoms, symptoms of infection 
range from gastroenteritis, influenza-like symptoms, respiratory tract infections, spasms 
of the limbs and neck, and may lead to the most severe form of infection, paralytic polio 
[10]. The ratio of asymptomatic to paralytic cases can range from 50:1 to 1000:1, making 
paralysis very rare [7], as seen in Figure 4. Patients are usually able to completely recover 
within 10 days unless motor functions are compromised longer than 12 months, in which 
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patients are then permanently disabled. In the fewer than 1% of cases in which paralysis 
does occur, the disease is classified into spinal, bulbar, and bulbospinal types varying on 
the location of the motor neurons that are affected. Initial clinical presentation of spinal 
poliomyelitis are often symptoms of meningitis and sensory and motor symptoms 
including hyperaesthesia, paraesthesia, and spasms [8]. These symptoms continue for 1-2 
days, after which further weakness and paralysis ensues. The weakness and paralysis that 
results are known as acute flaccid paralysis (AFP), which is characterized as asymmetric 
and flaccid, and primarily affects the lower limbs, however in severe cases, all limbs have 
shown to be affected. Bulbar poliomyelitis is a more serious form the disease that 
involves the cranial nerves that may present as encephalitis, making a differential 
diagnosis difficult. The mortality rate of polio varies depending on site of infection and 
age group but is approximately 5-15% in paralytic patients [8]. Post-polio syndrome can 
occur in patients 30 to 40 years after being infected with acute poliomyelitis. Symptoms 
include generalized fatigue, weakness, muscle atrophy, dysphagia, and may lead to 
respiratory failure [9]. The primary danger of polio infection is respiratory failure caused 
by paralysis of the respiratory muscles. Current diagnosis of polio is done via polymerase 
chain reaction (PCR) of primarily stool samples but throat swabs and cerebrospinal fluid 

















Figure 4. Outcomes of Poliovirus Infections. While the majority of cases are 





As mentioned previously, polio exhibited a sense of seasonality prior to the creation of a 
vaccine, peaking in the summer months of August and September. It was hypothesized 
that the reason for the spike during the warmer months coincided with the increase in 
possible person-to-person transmission due to increased human activity in the warmer 
summer months. To investigate, researchers compared the seasonality of rotavirus to that 
of polio (Figure 5). The peaks were not found to be at the same time, as one would 
predict using this hypothesis. Because of this, increased human activity and interaction 














Figure 5. Seasonality of Rotavirus Compared to Seasonality of Poliovirus. Poliovirus 
can be seen to show a significant peak during August and September. Rotavirus peak is 
seen in March and April. The poliovirus data was observed in New England from 1942-
1951. The rotavirus data was observed in the United States from 1991-1997. Because of 
the varying peaks, increased human activity during warmer months does not seem to be 
the reason poliovirus exhibited peaks in the summer months. Data from [1], [11], and 
[12]. 
 
Another hypothesis that exists is that the seasonality of poliovirus coincides with the 
relative humidity in geographical areas. Comparing data from New England and Hawaii, 
the poliovirus peak-to-trough ratio in New England was nearly 100-fold, but only 4-fold 
in Hawaii, displayed in Figure 6. Also, while the relative humidity in Hawaii remains 
relatively constant throughout the year, the humidity in New England shows marked 
variability over the year. It is hypothesized that survival of poliovirus depends on the 
relative humidity. Similar hypotheses exist for other viruses, such as influenza, exhibiting 
that different viruses are able to survive better in different conditions of humidity and 
 
 13 
temperature. Although there are many hypotheses for the seasonality of poliovirus, 
further studies need to be performed to determine the exact cause.  
 
Figure 6. Relative Humidity of New England and Hawaii in Relation to Poliomyelitis 
Seasonality. New England humidity during 1942-1951 showcases marked variation 
throughout the year with relative humidity peaking slightly before the peaks of poliovirus 
can be seen. Contrarily, relative humidity in Hawaii between 1938-1952 remains 
relatively constant throughout the year, coinciding with smaller peaks in poliovirus 
infections seen during the year. Data from [1], [13], and [14].  
 
 
Polio began gaining momentum in Europe in the late 1800s and early 1900s in countries 
such as Norway and Sweden. Emergence in the U.S. showed similar patterns as Europe, 
random, sporadic cases lead to small outbreaks which led to major epidemic events. 
Northeastern states were reporting significant amounts of cases, especially New York 
which had reported 2,500 cases by 1907 [15]. In the summer of 1916, New York was hit 
with a major polio epidemic. Because of the relative novelty of the disease, treatment was 
not specific and often symptomatic. Many treatments were used including intravenous 
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injection of the disinfectant hexamethylamine (urotoprin), hydrogen peroxide, adrenaline 
injection, lumbar punctures, and even distributing tetanus antitoxin in attempt to block 
virus access to nerve cell absorption [16]. Many of the treatments failed, causing further 
complications and death. Physicians and healthcare professionals were overwhelmed to 
the point that no meaningful statistics could truly be organized. Many cases went 
unreported, especially paralytic cases, as people were afraid of entering hospitals. 
Quarantines were put in place on New York City residents, shutting down entire 
neighborhoods. Medical certificates were given to children that stated that they were 
symptom-free, but many asymptomatic and thus, highly infectious patients were missed 
causing further spread of the virus. Thousands of cats, dogs, and flies were killed that 
summer as it was falsely believed that they were carriers of the virus. The epidemic 
resulted in nearly 9,000 cases of paralysis and nearly 2,500 deaths [17]. Although cases 
reduced slightly, polio remained a threat for decades after this epidemic with no vaccine 
in sight. The intensity, extent, and severity of this epidemic had never been seen before. 
The U.S. was also fighting in the Mexican Border War, with the peak of the war 
happening in 1916 which may have caused further dissemination of polio. Similar 
epidemics were occurring globally, causing a significant amount of death and major 
public health crisis. In 1952, the U.S. faced the worst polio outbreak in the nation’s 
history, further increasing the critical need for a vaccine. Important events in the history 
of polio that led to the need for a vaccine can be shown displayed in Figure 7.   
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Figure 7. Critical Events in the History of Poliomyelitis. Critical events in the U.S. 
that led to the urgency of creating a vaccine. Figure from [22].  
 
Vaccine Development, Use, and Efficacy 
 
At the annual American Public Health Association meeting in November 1935, two of 
the first experimental vaccines were developed in an attempt to combat polio. Maurice 
Brodie and Dr. John Kolmer had developed a killed and live vaccine, respectively and 
presented their results at the conference [18]. Both vaccines were deemed very 
problematic. Neither of the two researchers had performed extensive tests on animal 
models before attempting human trials, as human experimentation was not regulated by 
the law at that point in time. Both vaccines were delivered to thousands of children 
causing cases of paralysis and some cases were even fatal. In 1954 Jonas Salk, a 
physician from New York City, produced the first intramuscular inactivated polio vaccine 
(IPV). Under the direction of his mentor, Thomas Francis Jr., the vaccine underwent a 
placebo-controlled trial in which 1.6 million children in the U.S., Finland, and Canada 
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participated [19]. This large trial, although under great scrutiny by the general public, set 
the standard for establishing the necessity for double-blind and controlled trials for 
vaccines [20]. The results of the trial were promising, decreasing the number of paralytic 
polio cases in the U.S. from 13.9 cases per 100,000 in 1954 to 0.8 cases per 100,000 in 
1961 [21]. In April of 1955, Jonas Salk’s vaccine was approved for use in the U.S. 
Although it seemed as if the Salk vaccine was going to be the answer to polio, there were 
disadvantages to the vaccine. It was found that after a few years post-vaccination, 
circulating antibodies to the virus decreased. Also, a significant number of animal models 
(monkeys) needed to be used to develop the IPV. In April of 1955, the vaccine’s 
inactivation process was found to be defective at Cutter Laboratories in California which 
led to 40,000 new cases of polio, 200 cases of paralysis and 10 deaths specifically caused 
by the vaccine, the tragedy known as the Cutter Incident [23]. After further tweaking and 
alteration of the inactivation process of the vaccine, the potency and immunogenicity of 
the vaccine was enhanced. Multiple doses of the IPV were required, but trials exhibited 
nearly 100% seropositivity to all three PV types after two doses of the vaccine [24]. 4 
doses of IPV were given to the children followed by a booster dose a few years later. This 
schedule remains relatively the same today in the U.S. and many other developed 
countries. Overall, IPV exhibited incredibly quick translation from bench-to-bedside 
which can be attributed to previous research done on the influenza virus, sociopolitical 
factors such as President Franklin D. Roosevelt contracting polio, and the Cutter incident 
[22]. The creation of the Salk vaccine was a critical milestone in the now standard 
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development of vaccinations, especially in the U.S. The Salk vaccine was proved to be 
effective at reducing polio incidence (Table 2), especially considering its relative novelty. 
Racism and segregation were a major issue during the time of the Salk vaccine, which led 
to some racial groups receiving the vaccine at greater rates than other groups in the U.S., 














Figure 8. Distribution of Population Vaccinated with Salk Vaccine According to Age 
and SES in Kansas City, Missouri in June, 1959. The upper White population was best 
vaccinated while the Black population was poorly vaccinated, especially in the 0-4 age 







Table 2. Efficacy of Salk Vaccine in Kansas City, MO in 1959 
The Salk vaccine was proved to be effective in reducing polio incidence. In the White population 
of the 0-4 age group, which exhibited the most incidence, there were 34 nonparalytic cases 
among those unvaccinated, while only 4 cases existed in those vaccinated, yielding an 
approximately 80.4% effectiveness. In the Black population of the 0-4 age group, there were 26 
cases among those unvaccinated and only 1 case among those vaccinated, yielding an estimated 
effectiveness of 90.9%. The effectiveness of the vaccine in preventing both paralytic and 
nonparalytic cases was similar, approximated at 73.5% for nonparalytic cases and 76.8% for 




The creation of the IPV led to a massive reduction in the number of cases in the U.S. and 
worldwide, falling from more than 57,000 paralytic cases (in the U.S.) in 1952 to less 
than 5,500 paralytic cases in 1957 [4]. Even with the incredible success of the polio 
vaccine, Salk never patented his vaccine and never made a profit on it either.  
Figure 9. Paralytic Cases of Polio in the United States Since 1910. The number of 
paralytic cases reduced dramatically after the approved use of IPV around 1955. Figure 
modified from [4].   
 
 
Despite IPV being wildly successful as shown by Figure 9, a researcher physician named 
Albert Sabin set out to improve the current polio vaccine due to IPV’s drawbacks which 
include the reduction of antibody titers years after vaccination and it being neurotropic 
for monkeys during development. On August 6th, 1960, Sabin’s groundbreaking peer-




(JAMA), which discussed the efficacy of his live, orally given poliovirus vaccine (OPV) 
[26]. The major advantage of OPV being that it was able to mimic the wild poliovirus 
(WPV) in an individual but with significantly reduced ability to spread to the CNS. This 
allowed individuals receiving this vaccine to mount an effective immune response to the 
virus without becoming ill in the process. Sabin’s article described the efficacy of his 
vaccine which he gave to 26,033 children in Toluca, Mexico [27]. He used a trivalent 
mixture of the different poliovirus strains for his vaccine to obtain his goal of vaccinating 
the largest number of children with all vaccine strains and subsequently allowing further 
dissemination in the community via herd immunity. Table 3 shows the results of Sabin’s 
trial. 
Table 3. Development of Poliovirus Neutralizing Antibodies in Two Mexican Cities 
Antibodies to polio were developed in a considerably larger number of individuals in the 
population 10-weeks post-vaccination compared to the population that was not vaccinated, which 
was the goal of the study by Sabin. For individuals who did not develop antibodies within 10 
weeks of vaccination, another dose of the trivalent vaccine was given. Eventually, the total 
antibody conversion rate of the vaccine was 96% for types 1 and 2 and 72% for type 3. Table 
from [26]. 
 
Sabin’s vaccine quickly won acceptance due to its low cost, quick and simple 
administration through drops or sugar cubes, ability to disseminate immunity to non-
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vaccinated individuals (herd immunity), ability to induce a robust enteric immune 
response, and even political acceptability, in that it was endorsed by countries worldwide 
with opposing political systems [28]. Cuba endorsed and produced OPV in 1962 and led 
the first nationwide polio vaccination campaign [29]. In 1972, Sabin donated his vaccine 
to the WHO to help produce and further provide the vaccine globally. From 1961 to 
1978, the percentage of children who received the adequate three doses of OPV increased 




Table 4. Comparison of Oral Polio Vaccine (OPV) and Inactivated Polio Vaccine 
(IPV) 
Comparison of Oral Polio Vaccine (OPV) and Inactivated Polio Vaccine (IPV). 
Property of 
Vaccine 
Oral Polio Vaccine Inactivated Polio Vaccine 
Preparation Live attenuated poliovirus 
serotypes (Sabin types 1, 2, 
and 3), in a 10:1:3 ratio, 
respectively. 
Strain of each of the 3 serotypes that 
have been inactivated (killed) with 
formalin, adsorbed onto adjuvants. 
The final vaccine mixture contains 40, 
8, and 32 D-antigen units of serotypes 
1, 2, and 3, respectively. 
Valency Trivalent OPV (tOPV) and 
monovalent, against type 1 
(mOPV1) and against type 3 
(mOPV3) bivalent (type 1 
and type 3) OPVs (bOPVs) 
Only 1-type trivalent 
Storage +2°C to +8°C. Should be 
protected from light. Any 
vaccine showing particulate 
matter, turbidity, or change 
in color should be discarded 
+2°C to +8°C. Should be protected 
from light. Any vaccine showing 
particulate matter, turbidity, or change 
in color should be discarded 
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Pathogenesis Produce a local immune 
response in the intestines. 
Mucosal immunity decreases 
the replication and shedding 
of the virus 
Antibodies are produced against the 
polio virus which provide humoral 
immunity, thus decreasing the 
replication of the virus. 
Administration Through mouth as drops Intramuscularly into the upper arm or 
anterolateral thigh, can be 
administered alone or in combination 
with other vaccines 
Recommended 
dosage 
No longer in use in polio-
free countries like United 
States and United Kingdom. 
Used routinely only in polio 
campaigns in high risk and 
endemic areas 




Immunity from oral 
poliovirus vaccine is 
probably lifelong. OPV 
produces excellent gut 
immunity 
The duration of immunity with IPV is 
not known with certainty. Highly 
effective in producing immunity to 
poliovirus and protection from 




Characteristics of each vaccine are described. Table from [7].  
 
 
Eventually, it was recognized that there were major risks associate with OPV, including 
the appearance of Vaccine-Associated Paralytic Poliomyelitis (VAPP) along with the 
emergence of novel circulating Vaccine Derived Poliovirus (cVDPV) strains, which 
differ slightly in nucleotide sequence from the original vaccine strains [30]. When the 
vaccine strains replicate in the lymph tissue of the intestine, they can acquire variation 
and point mutations which allow reversion of the strains resulting in neurovirulence. 
Although the appearance of VAPP was rare, estimated at one case per 750,000 doses of 
the first dose of OPV and one case per 6.9 million in subsequent doses [31], this was still 
an area of concern. cVDPV strains were likely the result of replication of vaccine strains 
in immunodeficient recipients exposed to OPV. After a large amount of adjustments, 
WHO intervention, and trial and error, it was eventually learned that although OPV was 
very effective in reducing paralytic polio as shown by Figure 10 and Figure 11, it could 
be hazardous to administer to the general population. While the low cost, easy 
administration, and effectiveness of OPV were appealing, VAPP and cVDPV were issues 
Adverse effects Vaccine-associated paralytic 
poliomyelitis (VAPP) 
outbreaks due to circulating 
vaccine-derived poliovirus 
(cVDPV) 
Adverse events following 





that needed to be addressed. Many countries eventually switched to a combination of 











Figure 10. Annual Numbers of Reported Cases of Polio in the U.S. This figure shows 
the number of cases decreasing dramatically especially after the introduction of both IPV 
and OPV in the United States. From 1972-1982, cases were mostly either imported cases 
or VAPP cases. Figure from [1], [32] and [33].  
 
Eventually, the significant reduction of polio cases in the U.S. and other developed 
countries led governments and various organizations to realize that eradication in other 
regions was possible. Under progressive leadership, Cuba was one of the first countries to 
 
 26 
successfully eradicate polio. Both Cuba and Brazil accomplished this by undergoing a 
robust immunization campaign. The program was a massive success, leading to the 
eradication of indigenous wild polioviruses by 1994 in the Americas [34]. Figure 12 and 





















Figure 11. Reported Number of Cases of Paralytic Polio in Latin America and 
Caribbean Region in Relation to Percentage of Children Receiving OPV. Dashed line 
represents the percentage of children aged 12 months given at least 3 doses of OPV. As 
the percentage of children receiving OPV increased, the number of paralytic cases 














Figure 12. Global Incidence of Confirmed Polio Cases from 1985-2010. The GPEI 
began in 1988 and since then cases have greatly diminished globally, including a 
dramatic reduction in paralytic cases. Data from [38]. 
Figure 13. Immunization Coverage with 3rd Dose of Polio Vaccine in Infants in 2018. 
Map showcasing the widespread global vaccination programs that took place and are still 
in effect today under the GPEI. A majority of countries have vaccinated greater than 90% 
of infants as of 2018, with many more countries close behind. Figure from [39].  
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In 1988, the WHO established the Global Polio Eradication Initiative (GPEI) in an effort 
to eradicate wild poliovirus globally. Large immunization programs took place with an 
emphasis on getting as many people immunized as possible. The GPEI was incredibly 
successful and still is to this day, as shown in Figure 14. It is estimated that there was 
nearly a 99% reduction in the polio burden globally [36]. Also, paralytic cases (due to 
PV2) were completely eradicated and were last reported in Uttar Pradesh, India in 1999. 
[37]. Once endemic in over one hundred countries globally, polio became endemic in less 
than 10 in the early 2000s. Nigeria reported its last case of wild poliovirus in August of 
2016 and had therefore successfully eradicated polio. In 2020, Afghanistan and Pakistan 














Figure 14. World Map of Polio Cases in 1988 and 2018. As of 2020, Nigeria is no 
longer considered endemic with polio. Pakistan and Afghanistan are the only two 
countries in which polio is still endemic in 2020. The GPEI has been greatly successful in 




Polio in Pakistan 
 
In 2014, the WHO declared polio a Public Health Emergency of International Concern 
(PHEIC) in an attempt to completely eradicate circulating wild poliovirus from the three 
remaining countries that were endemic with polio: Afghanistan, Nigeria, and Pakistan. 
There are many problems that make complete global eradication of polio difficult which 
include failure to vaccinate, failure of the vaccine itself, and vaccine-associated cases. In 
2014, Pakistan had the presence of three polio serotypes: wild poliovirus 1 (WPV1), 
cVDPV1, cVDPV3 that were all capable of international spread [41]. With more than 
220 million people, Pakistan is one of the most populated countries in the world. Children 
under the age of five represent nearly 6.6% of the country’s total population but 
vaccinating this group has been a significant challenge [42]. Pakistan is divided into four 
major provinces: Balochistan, Khyber Pakhtunkhwa (KP), Sindh, and Punjab. Although 
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OPV coverage rates are some of the highest there, Northern Punjab often deals with 
outbreaks of WPV due to neighboring endemic areas [43]. Failure to vaccinate is a major 
problem in both Afghanistan and Pakistan and some of this issue can be attributed to 
geography. Since the two countries border each other, ongoing cross-border transmission 
is an issue of major concern. Vaccinating in border areas has been a significant challenge 
for healthcare workers and organizations. The PHEIC declared by the WHO was enacted 
in order to catalyze political support of mass-polio vaccination campaigns as well as to 
interrupt further WPV transmission [41]. Also, this campaign allowed testing of 
environmental samples for WPV and tracking cVDPV cases. Refusal to vaccinate by 
families is also a significant problem in the fight towards eradication, which can be 
attributed to terroristic pressure, local religious beliefs, lower education levels, and 
distrust of political organizations. A major scandal in 2011 involving the U.S. Central 
Intelligence Agency (CIA) near Abbottabad, Pakistan may have tainted years of 
vaccination efforts in Pakistan years. In an effort to collect familial DNA in the 
neighborhood where Osama bin Laden was believed to be hiding, the CIA funded a sham 
Hepatitis B vaccination program. Once citizens became aware of the fake vaccination 
program, major distrust of the public health sector ensued. To this day, this distrust has 
persisted throughout the country, especially in the border areas between Pakistan and 
Afghanistan. For many in these areas, vaccinations are seen as a Western ploy to sterilize 
females or harm children, making eradication of polio an incredibly difficult task. Despite 
these challenges, there has been significant progress in reducing the number of polio 
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cases in Pakistan. Under the PHEIC after 2014, national vaccination coverage was largely 
increased using three or more doses of OPV and occasionally IPV in an effort to further 
increased immunity within the population. Mass-vaccination campaigns through national 
and subnational immunization days contributed to large increases in immunized children, 
with the province of Punjab even reaching nearly 100% OPV coverage for all children in 
2016 and 2017 (Figure 15). In November of 2017 alone, nearly 38.8 million children 
were vaccinated with 1.26 million vaccinations occurring at Permanent Transit Points 
such as bus stops, highways, and railway stations [45]. Vaccinations at Permanent Transit 
Points were established in an effort to reach children that may have not been vaccinated 
due to travel. During the time period of January 2016 to September 2017, there were 25 
WPV1 cases reported in Pakistan, which was a 69% decline compared to the same time 
period during 2015-2016 [44]. A majority of these WPV1 cases were reported in 2016 
with significantly less occurring in 2017 (8 cases in 2017). In addition to the decreased 
number of cases, there were only five districts which reported cases in 2017, compared to 
14 districts reporting in 2016 (Figure 16). Despite the strong decline in WPV1 cases in 





Figure 15. Number of WPV1 Cases in Pakistan from 2015-2019. Under the PHEIC by 
the WHO in 2014, cases dramatically reduced which may be attributed to successful 
mass-vaccination campaigns. 2019 saw a significant increase in the number of cases. 







Figure 16. Location of WPV1 cases in Pakistan from January 2016-September 2017. 
In 2017, only five provinces reported new WPV1 cases compared to 14 provinces in 
2016 reporting WPV1 cases. The decrease in provinces reporting cases may be due to 
increased vaccination within communities but could be attributed to a number of other 
factors. Figure from [44].  
 
 
Despite significant progress towards eradication in 2016 and 2017, progress has stagnated 
recently due to difficulty immunizing areas such as Federal Administered Tribal Areas 
(FATA), areas on the border between Afghanistan and Pakistan that are often conflict-
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afflicted. Terrorism is a constant issue in FATA and many governmental programs are 
often banned because of this, including vaccination programs. Reduced governmental 
intervention may also be the reason behind the area’s very low literacy level, cultural 
beliefs, misconceptions on religion, and conflict-afflicted border with Afghanistan which 
make eradication an even more difficult feat. In 2017, it was measured that at least 44.2% 
of children had never been enrolled in school in FATA. Also, the overall adult literacy 
rate in FATA was an incredibly low 28.4%, compared to Pakistan’s national average of 
57% [46]. Low literacy rates contribute to the misconceptions that vaccinations are a 
Western effort to sterilize children as well as vaccinations being incorrectly deemed un-
Islamic. Another issue with polio eradication is the lack of vaccinators, especially in 
areas such as FATA. Many polio workers fear for their lives as they have previously been 
targeted by militant groups in politically unstable areas, again likely due to the 
misconceptions about vaccinations. Additionally, polio workers are often subjected to 
low or lack of pay, lack of incentives, and issues with mobility, and lack of motivation to 
perform their job routinely and adequately [47]. Earthquakes and floods have historically 
affected Pakistan, exacerbating the difficulties reaching children in the more distant areas 
of Pakistan and destroying infrastructure without adequate methods to rebuild. Poor 
political and healthcare sector management has affected the lives of millions. Bribery, 
corruption, weak leadership, and poor healthcare delivery systems have led to the failure 
of many attempts at advancements in healthcare [48]. Underfinanced immunization 
infrastructure creates further barriers to polio eradication. There is an overall lack of 
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responsibility that exists at all levels of the infrastructure, from politicians to volunteer 
vaccinators, that has delayed the progression towards eradication. As a less-developed 
country, Pakistan faces a great deal of power outages, electricity supply issues, and load 
shedding that sometimes can last over 18 hours at a time. Because of the constantly 
interrupted electrical supply, Pakistan often lacks the necessary cold chain, an adequate 
system of vaccine storage and transport (Figure 17), needed to keep vaccines in good, 
usable condition [49]. OPV can lose up to 13% of its potency per day at a temperature of 
25 degrees Celsius and up to 34% potency per day at 37 degrees Celsius, temperatures 
that are typical in Pakistan’s hot climate [53]. It is likely that the OPVs used in Pakistan 
are often subject to loss of potency. Vaccine inefficacy results in people incorrectly 
assuming they have been adequately vaccinated [50]. Initially, in Pakistan a trivalent 
OPV (tOPV) was used, but was found to have reduced effectiveness against PV1 and 
PV3 strains [51]. Consequently, monovalent OPVs were used individually composed of 
PV1 and PV3 strains. Eventually, the WHO combined the two serotypes to create one 
bivalent OPV that contains both PV1 and PV3 strains. With continued use of the bivalent 
OPV, WPV cases began to diminish but cVDPV cases began to increase that were likely 
due to continued use of low doses of OPV [52]. cVDPV remains a major issue in 
Pakistan, with nearly 70 current cases in the country as of June 2020 [52]. Combinations 
of OPV are still used in Pakistan due to its ease of use and lower cost relative to IPV, but 




Figure 17. WHO Protocol for Cold Chain Maintenance of Vaccines. With regular 
electrical interruptions in Pakistan, maintaining the cold chain necessary for vaccines 




Conflict with Afghanistan is a continuous issue in the way of polio eradication in 
Pakistan. With the presence of both internal corrupt leadership and external terrorism 
threats in both countries, citizens are placed in difficult situations especially in border 
areas. The GPEI struggles to vaccinate citizens in these areas, having to deal with two 
politically-troubled countries while trying to preserve the safety of all parties involved. 
For polio to be eradicated in the nation of Pakistan, significant challenges must be 
overcome through campaigns that focus on infrastructure adjustments, sufficient funding, 
community engagement, independence of healthcare advancement from political issues, 
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and much more. Figure 18 displays critical events in the timeline of the polio eradication 
campaign in Pakistan. Bottlenecks to the campaign are shown in Figure 19. 























Figure 19. Bottlenecks to Polio Eradication Campaign in Pakistan. SIAs, 





As of 2018, the number of polio cases had reduced 99 percent since 1988 under increased 
activity from the WHO, Rotary International, UNICEF, CDC, and the Bill and Melinda 
Gates Foundation [55]. Progress has stagnated as a result of the factors previously 
mentioned. There are a multitude of methods that can be used to help eradicate polio each 
with different effectiveness.  
 
In 2017, global leaders pledged $1.2 billion towards attempting to achieve a polio-free 
world. Including funds received in the years prior, an additional $300 million funding gap 
remained in 2020 [56]. As a longtime contributor to the GPEI, the Government of 
Germany offered an additional €2 million to the polio-eradication effort to Pakistan in 
2017 [57]. One possible method to help eradicate polio globally is to increase funding 
under the GPEI. Pakistan can utilize the increased funding to accomplish many objectives 
including increased vaccine availability, improved vaccine cold chain maintenance and 
technology, increased pay of polio workers, effective communication among staff, 
increased number of national immunization days, and much more. In order for these 
objectives to be met under increased funding, it would be imperative that the funds are 
allocated appropriately. In order for the funds to be allocated properly, the core partners 
that lead the GPEI must be held accountable to ensure that funds will go towards the 
proper causes and not towards the advancement of political parties or figures in Pakistan. 
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Increased funding would not be able to eradicate polio on its own, but would offer an 
important stepping stone in the right direction.  
 
Likely the most important objective that must be met to not only eradicate polio, but to 
create systematic change in Pakistan is to increase the number of citizens that are 
educated, especially women. With increased education, theories about vaccines being a 
Western ploy to harm children would be significantly less impactful among families and 
lead to more families willing to vaccinate their children. Also, as more people become 
educated, the next generation of politicians, healthcare administrators, and even the 
working-class could lead to radical systematic change in all sectors of Pakistan. Pakistan 
is dealing with a major population issue with a population density of 169/km2 (compared 
to 28/km2 in the USA); increased education could help educate the lower class about 
family planning and the importance of birth control [58]. With a lower population 
density, the overall socioeconomic conditions of Pakistan would improve and lead to a 
more advanced society in all aspects. Currently, a significant number of Pakistani 
children are out of school, as shown by Figure 20. Increased education can be achieved 
by enforcing and funding the Universal Primary Education (UPE) program led by the 
United Nations (UN). The focus of this campaign is that education is a basic human right 
and it works to achieve its objective by placing pressure on governments and the 
community to ensure primary public education for all. Increased funding would promote 
an increase in the number of teachers if they are being paid appropriately, subsequently 
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increasing the teacher-student ratio and also increasing the number of schools in all areas. 
It is important for schools to be accessible to children in regard to location and safety. A 
common problem in Pakistan is the invention of “ghost schools” which employ teachers 
that receive fully paid salaries, but teach no students [59]. These schools are again a 
result of corruption at the top level, misallocating funding for political and personal gain 
rather than for what it is intended for. The large number of these schools indicate that the 
existence of schools does not guarantee student enrollment and retention, but the 
functioning of schools depends on their integration into the community and established 
institutional structures [60]. Therefore, it is very important for the government to promote 
education, and make it easier for children to enroll and stay in school throughout their 
childhood and adolescent years. Funding must also be allocated properly towards causes 
that can directly benefit the people of Pakistan. Figures 21A, 21B, and 21C display 
examples of systematic effects that increasing education can have on Pakistan.  
Figure 20. Out of School Children by Gender and Region in Pakistan in 2015. The 
graph indicates that although there is a problem with both boys and girls not enrolled in 
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school in Pakistan, girls are especially affected. Nearly 44% of children aged 5-16 are not 
enrolled in school [61]. This is an issue that UPE is attempting to solve through increased 



















Figure 21A. Potential Effects of Increasing Education in Pakistan. This figure 
demonstrates the issue that politicization of education can have on the entire education 
system in Pakistan. With greater politicization, progressive educational policies would 
decrease and cultural barriers to education would increase, leading to decreased numbers 
of students in the education system. Contrarily, if literacy rates increase without the 
politicization of education, the quality of the education system increase, lowering the 






























Figure 21B. Potential Effects of Increasing Education in Pakistan. According to this 
figure, with increased investment in the education sector, the stability of the government 











Figure 21C. Potential Effects of Increasing Education in Pakistan. According to the 
figure, with decreased politicization of education, a plethora of positive effects can occur 
in Pakistan. Some of these positive effects include decreased dropout rate, increased 
number of students in the education system, decreased attractiveness of extremist 
organizations, more positive foreign perception of Pakistan, increased foreign support for 




As part of one of the strongest militaries in the world, Pakistan’s soldiers are well 
respected in the community as they instill a sense of safety and trust among citizens. 
Political leaders should utilize the country’s large military to travel into conflict-afflicted 
areas, such as FATA, to promote vaccination in the population. It is likely that 
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uneducated citizens are more likely to trust the distinguished soldiers rather than political 
and social organizations that they may have lost trust in due to prior events. In order for 
soldiers to accomplish this task, they must be trained to properly administer vaccines in a 
safe and effective way. Soldiers must also have the desire to work towards eradication so 
that the job is done properly. To accomplish this, they could be incentivized through extra 
pay or more benefits, in addition to the exceptional benefits soldiers already receive, such 
as farm lands and housing plots [63]. It is common for polio workers and vaccinators to 
lack the motivation necessary to properly vaccinate, especially workers of door-to-door 
campaigns. It was found that among 386 health personnel surveyed in KP and Islamabad, 
only 1.6 percent believed that polio was the most important health challenge currently 
affecting Pakistan [67]. Both monetary and nonmonetary incentives for workers could 
possibly help solve these issues. Along with military involvement, Pakistan can utilize 
social and religious activists to help complete their task. The late Abdul Sattar Edhi, also 
known as Edhi, dedicated his life to humanitarian work in Pakistan. Edhi worked in all 
sectors of Pakistani life including education and healthcare to make the country a better 
place for all. Polio vaccination campaigns should seek out people like Edhi who are 
trustworthy, well-respected in the community and truly want to improve Pakistan. Again, 
Pakistani citizens are much more likely to trust renowned activists than government-




Another method that could be used to combat polio transmission is mandatory 
vaccination at birth. While this method seems unethical and is unlikely to work in a 
more-developed country, temporarily requiring vaccination upon birth may significantly 
decrease transmission of the virus in the years to come. In early 2019, the Sindh province 
of Pakistan enforced mandatory vaccinations of all children entering public and private 
schools [64]. If all provinces of Pakistan adopted this policy, the transmission of polio 
could reduce dramatically. It should be a requirement for all children to be vaccinated in 
order to attend school, much like U.S. schools’ stringent list of vaccinations prior to 
enrollment. This task could be accomplished by vaccinating all children that are born in 
Pakistani hospitals. If the family decides to decline vaccination without acceptable 
reasoning, then they may be subject to legal trouble or fines. Despite this method’s 
potential, a study revealed that many women in Pakistan give birth at home. The study 
reveals that the percentages of children born at home are: 74% in Balochistan, 53% in 
Khyber-Pakhtunkhwa, 46% in Gilgit Baltistan, 45% in Punjab, and 34% in Sindh [65]. In 
order to reach as many children as possible, mandatory vaccination for hospital births in 
combination with door-to-door campaigns and national immunization days would likely 
yield the best results. Considering that mass-movements across the Pakistan-Afghanistan 
border are so common, vaccine mandates at the border should also be enforced. Migrants 
entering Pakistan should be vaccinated for polio and should carry documents confirming 
their immunity. If not vaccinated, free vaccinations should be provided. This temporary 




In the age of social media and advanced technology, taking advantage of the large 
Pakistani social media presence would be incredibly beneficial in the fight against polio. 
Sites and social media applications such as Facebook, Twitter, and WhatsApp are heavily 
used among the Pakistani people. In 2013, Israeli healthcare administrators and 
physicians created a Facebook group promoting polio vaccinations and answered 
questions from the general public about any concerns they might have about vaccinations 
[66]. Pakistan could create similar campaigns, but physicians and healthcare workers 
would have to volunteer time to individually answer people’s concerns, rather than 
simply replying with generic answers. Healthcare workers could be offered extra pay or 
incentives to partake in the program as well. WhatsApp is one of the major forms of 
communication used in Pakistan. Often, home remedies to serious medical problems 
circulate on the app. Polio vaccination campaigns should aim to create powerful, eye-
catching images and videos that display influential messages about the benefits of 
vaccinations with the goal of becoming viral. If the messages can reach enough people, 
they may be able to influence people to vaccinate their children. The messages could 
utilize important figures in pop culture such as actors, musicians, and even athletes. 
Advertisements that include renowned television and movie stars promoting the 
vaccination of children could create large movements towards a safer country, especially 




In 2014, India was declared a polio-free country as no cases of WPV had been reported 
since 2011 [68]. As a neighboring country, Pakistan should model their polio eradication 
campaign after India. As one of the most populated countries worldwide, India’s success 
should serve as a sense of hope that eradication is definitely possible in Pakistan. 
Eradication in India can be attributed to commitment by the Indian government, and 
cooperation between WHO, Rotary International, and UNICEF. Complete commitment 
by the government and citizens, district planning, improved vaccination rates in 
troublesome areas, and utilization of advanced technology are all important objectives 
that need to be met in order to accomplish eradication.                                                     
                   
Intercountry communication and cooperation would also be necessary in the fight 
towards eradication, as established countries are able to allocate important resources and 
funding towards the cause, as noted previously by the generous contribution by Germany. 
A polio-free world should be a goal of every country worldwide. Although, complete 
commitment towards the cause would be necessary starting with the Pakistani 
government and citizens. In 2009, under President Barack Obama the U.S. launched a 
joint campaign with the Organization of Islamic Cooperation, an organization that 
includes many countries globally, to eradicate polio globally [69]. The campaign works 
to bring support to the endemic countries affected by polio by mobilizing resources and 
financial contributions, as shown in Figure 24. In 2021, the U.S. has proposed to 
significantly reduce funding towards the campaign [69]. Experts are worried that funding 
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and resources from the U.S. will decrease even more in the years to come due to the 
lasting effects of the COVID-19 pandemic. As a political powerhouse, it is imperative for 
the U.S. administration to continue its support towards polio eradication. Global 
cooperation and contributions will be necessary in order to make polio one of the few 
fully eradicated diseases worldwide. Overall, total funding from the GPEI has increased 
over the years (Figure 25) and it must continue to do so if polio eradication is the goal. 
 
Figure 22. U.S. Funding Towards Global Polio Eradication by Year. In 2021, the 
U.S. plans to significantly reduce its funding toward the global polio eradication 
campaign. As one of the major contributors to the GPEI, this may create significant 




Figure 23. GPEI Financial Contributions from 1998-2019. Although in some years the 
annual amount contributed was less than the year prior, cumulative totals have increased 
each year since 1998. It is imperative that adequate funding is continually allocated 
towards the cause yearly to achieve the goals of polio endgame. *2019 reporting was not 
complete at the time of publication. Figure from [70].  
 
cVDPV cases are another significant issue that must be combatted in Pakistan. cVDPV 
are a result of low coverage of OPV. As a result, the WHO has slowly begun to phase out 
OPV and replace parts of the series with IPV, with the goal of ending use of OPV 
entirely. Despite its ease of use, the concern of cVDPV cases is the main reason for the 
switch. Although difficult, the WHO should phase out OPV in a more-urgent manner in 
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order to diminish cVDPV cases as soon as possible, especially in a country like Pakistan 




CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
The various methods of achieving global eradication of polio mentioned previously could 
all prove to be successful individually but utilization of all of them in combination would 
be ideal and create significant advancement towards eradication. While some methods 
have already been successful such as increased funding and education, novel methods 
such as social media campaigns, training military soldiers, forced vaccinations, and 
modeling campaigns after other countries have yet to be attempted. Funding and 
education should continue to be used and even ramped up as they have been proven to be 
incredibly successful not only in reducing polio cases in Pakistan, but they have the 
potential to create systematic change in all sectors as mentioned previously. Commitment 
towards polio endgame and the elimination of corruption in the Pakistani government is 
necessary to ensure resources are appropriately allocated. This can be accomplished by 
educating the Pakistani people, especially children. Significantly increasing the number 
of educated citizens should be the primary long-term goal of the country, as the next 
generation has the potential to fix the issues of Pakistan brought upon by the previous 
generation, such as systematic corruption and the weak healthcare sector.  
 
Future work in the polio endgame strategy must begin with full, all hands-on deck 
commitment by the Pakistani government in achieving eradication. All officials must be 
onboard in order to advance the nation’s lackluster healthcare sector. Next, Pakistani 
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officials and experts should study the eradication plan used by India and model a very 
similar campaign after it. India’s plan will serve as an exemplary model to mimic as the 
issues that exist in India such as overpopulation, extreme poverty, and high rates of 
illiteracy, are issues that plague Pakistan as well. Social media campaigns that include 
pop culture figures such as actors and musicians should be enacted in an effort to make 
vaccination “trendy” and a step towards improving Pakistan. Vaccinating children should 
be seen as nationalistic and give a sense of pride to those that partake so that they feel as 
if they are helping the fight towards improving their country. A culture of collectivism 
must take precedence over individualism in order for the goal to be achieved. Forced 
vaccination at birth and at border areas utilizing military soldiers could be considered to 
those that feel as if vaccination is unnecessary or optional. Although it is likely that this 
would create significant criticism and backlash aimed at the government, a strong stand 
by those in charge must be taken at this point. While the entire polio eradication 
campaign is occurring, improving education should be at the forefront of the operation. 
Increasing the number of schools, training more teachers, enrolling more children and 
women in school, and adequately paying school staff is imperative to create a better 
future for Pakistan.  
 
As more is studied about polio endgame strategy, more robust methods can be utilized 
but again, the strategy must begin with commitment. Extensive dedication and review of 
various methods must be done in order to develop a complete and vigorous polio 
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eradication strategy. If the necessary steps are taken with complete commitment, 
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